CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE14998.70346.2 (+2.36 %)
PREV CLOSE () 14652.50
OPEN PRICE () 14600.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1398
TODAY'S LOW / HIGH ()14502.00 15025.00
52 WK LOW / HIGH ()10598.05 19748.4
NSE15003.00347 (+2.37 %)
PREV CLOSE() 14656.00
OPEN PRICE () 14605.00
BID PRICE (QTY) 15003.00 (93)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 26786
TODAY'S LOW / HIGH() 14464.00 15040.00
52 WK LOW / HIGH ()10578 19747
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984

Management Info :

Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director

Registered Office :

Address : 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone : 040-67611600 / 67611700

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
29Apr Neuland Laboratories submits earnings
Neuland Laboratories has informed that the company will announce its res..
14Apr Neuland Laboratories informs about new
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
14Apr Neuland Laboratories informs about pre
Neuland Laboratories has informed that it enclosed copies of newspaper a..
11Mar Neuland Laboratories informs about new
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
04Feb Neuland Laboratories informs about ana
Neuland Laboratories has informed that the Company’s management will be..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit404.172594.26
Gross Profit 542.72 3453.74
Operating Profit 849.793428.08
Net Sales 4397.0914768.37
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
RPG Life Sciences (BSE)
 2297.45 (13.59%)
M.Cap ( in Cr)
3799.76
Fredun Pharma (BSE)
 2230.90 (6.37%)
M.Cap ( in Cr)
1229.83
Acutaas Chemicals (BSE)
 2596.55 (3.84%)
M.Cap ( in Cr)
21258.25
Procter&Gamble Healt (BSE)
 5194.55 (1.33%)
M.Cap ( in Cr)
8622.63
Alkem Laboratories (BSE)
 5404.05 (1.14%)
M.Cap ( in Cr)
64613.52
Shareholding Pattern
PROMOTERS 32.63%
NON-INSTITUTION 31.07%
MUTUAL FUNDS/UTI 11.35%
FI/BANKS/INSURANCE 1.3%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX76913.50-582.86 (-0.75%)
NIFTY23997.55-180.10 (-0.74%)
Dow Jones 48861.81-280.12 (-0.57%)
Nasdaq 24673.249.44 (0.04%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI